Effects of intensified conditioning on Epstein-Barr virus and cytomegalovirus infections in allogeneic hematopoietic stem cell transplantation for hematological malignancies (Q36173285)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Effects of intensified conditioning on Epstein-Barr virus and cytomegalovirus infections in allogeneic hematopoietic stem cell transplantation for hematological malignancies	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Effects of intensified conditioning on Epstein-Barr virus and cytomegalovirus infections in allogeneic hematopoietic stem cell transplantation for hematological malignancies (English)

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Epstein–Barr virus

0 references

Cytomegalovirus

0 references

cytomegaloviral disease

1 reference

based on heuristic

inferred from title

author name string

Li Xuan

1

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Fen Huang

2

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Zhiping Fan

3

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Hongsheng Zhou

4

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Xian Zhang

5

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Guopan Yu

6

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Yu Zhang

7

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Can Liu

8

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Jing Sun

9

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Qifa Liu

10

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

publication date

2 August 2012

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Journal of Hematology & Oncology

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

5

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

46

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Allogeneic hematopoietic stem cell transplantation in China: where we are and where to go.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3422173

1 October 2017

Strategies to Prevent EBV Reactivation and Posttransplant Lymphoproliferative Disorders (PTLD) after Allogeneic Stem Cell Transplantation in High-Risk Patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3422173

1 October 2017

Surveillance of active human cytomegalovirus infection in hematopoietic stem cell transplantation (HLA sibling identical donor): search for optimal cutoff value by real-time PCR.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3422173

1 October 2017

Risk factors for lymphoproliferative disorders after allogeneic hematopoietic cell transplantation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3422173

1 October 2017

Epstein-Barr virus-associated lymphoproliferative disease after allogeneic haematopoietic stem cell transplantation: molecular monitoring and early treatment of high-risk patients.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3422173

1 October 2017

Novel strategies for relapsed and refractory acute myeloid leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3422173

1 October 2017

Immune reconstitution after allogeneic stem cell transplantation with reduced-intensity conditioning regimens

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3422173

1 October 2017

Risk assessment in haematopoietic stem cell transplantation: conditioning

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3422173

1 October 2017

Post-transplant lymphoproliferative disease and other Epstein-Barr virus diseases in allogeneic haematopoietic stem cell transplantation after introduction of monitoring of viral load by polymerase chain reaction.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3422173

1 October 2017

Long-term survival in refractory acute myeloid leukemia after sequential treatment with chemotherapy and reduced-intensity conditioning for allogeneic stem cell transplantation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3422173

1 October 2017

Cause of death after allogeneic haematopoietic stem cell transplantation (HSCT) in early leukaemias: an EBMT analysis of lethal infectious complications and changes over calendar time

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3422173

1 October 2017

Definitions of cytomegalovirus infection and disease in transplant recipients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3422173

1 October 2017

Diagnosis and treatment of posttransplantation lymphoproliferative disease after hematopoietic stem cell transplantation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3422173

1 October 2017

Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3422173

1 October 2017

Melphalan and purine analog-containing preparative regimens: reduced-intensity conditioning for patients with hematologic malignancies undergoing allogeneic progenitor cell transplantation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3422173

1 October 2017

Marked increased risk of Epstein-Barr virus-related complications with the addition of antithymocyte globulin to a nonmyeloablative conditioning prior to unrelated umbilical cord blood transplantation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3422173

2 July 2018

Allogeneic hematopoietic cell transplantation without myeloablative conditioning for patients with advanced hematologic malignancies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3422173

2 July 2018

Cytosine arabinoside as a major risk factor for Streptococcus viridans septicemia following bone marrow transplantation: a 5-year prospective study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3422173

2 July 2018

Sequential intensified conditioning and tapering of prophylactic immunosuppressants for graft-versus-host disease in allogeneic hematopoietic stem cell transplantation for refractory leukemia

1 reference

https://api.crossref.org/works/10.1186%2F1756-8722-5-46

21 January 2018

Cytomegalovirus infection and disease after allogeneic hematopoietic stem cell transplantation: experience in a center with a high seroprevalence of both CMV and hepatitis B virus

1 reference

https://api.crossref.org/works/10.1186%2F1756-8722-5-46

21 January 2018

Epstein-Barr virus-associated pneumonia in patients with post-transplant lymphoproliferative disease after hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1186%2F1756-8722-5-46

21 January 2018

Reactivations of cytomegalovirus, human herpes virus 6, and Epstein-Barr virus differ with respect to risk factors and clinical outcome after hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1186%2F1756-8722-5-46

21 January 2018

The impact of early viral infections and graft-versus-host disease on immune reconstitution following paediatric stem cell transplantation.

1 reference

https://api.crossref.org/works/10.1186%2F1756-8722-5-46

21 January 2018

The influence of infection early after allogeneic stem cell transplantation on the risk of leukemic relapse and graft-versus-host disease.

1 reference

https://api.crossref.org/works/10.1186%2F1756-8722-5-46

21 January 2018

Incidence and outcome of cytomegalovirus infections following nonmyeloablative compared with myeloablative allogeneic stem cell transplantation, a matched control study

1 reference

https://api.crossref.org/works/10.1186%2F1756-8722-5-46

21 January 2018

Management of HSV, VZV and EBV infections in patients with hematological malignancies and after SCT: guidelines from the Second European Conference on Infections in Leukemia

1 reference

https://api.crossref.org/works/10.1186%2F1756-8722-5-46

21 January 2018

Infections after allogeneic hematopoietic stem cell transplantation with a nonmyeloablative conditioning regimen

1 reference

https://api.crossref.org/works/10.1186%2F1756-8722-5-46

21 January 2018

Targeted monitoring of patients at high risk of post-transplant lymphoproliferative disease by quantitative Epstein-Barr virus polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1186%2F1756-8722-5-46

21 January 2018

Dose-escalated donor lymphocyte infusions following reduced intensity transplantation: toxicity, chimerism, and disease responses.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3422173

23 September 2018

Standard versus alternative myeloablative conditioning regimens in allogeneic hematopoietic stem cell transplantation for high-risk acute leukemia.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3422173

23 September 2018

Non-myeloablative hematopoietic stem cell transplantation is of limited value in advanced or refractory acute myeloblastic leukemia. The Mexican experience

1 reference

https://pubmed.ncbi.nlm.nih.gov/22856463

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Human herpesvirus 6 (HHV-6)-associated pleurisy after unrelated cord blood transplantation in children with chemotherapy-resistant malignant Lymphoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/22856463

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prospective study of infectious complications in allogeneic hematopoietic stem cell transplant recipients

1 reference

https://pubmed.ncbi.nlm.nih.gov/22856463

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nonablative versus reduced-intensity conditioning regimens in the treatment of acute myeloid leukemia and high-risk myelodysplastic syndrome: dose is relevant for long-term disease control after allogeneic hematopoietic stem cell transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/22856463

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A comparison of busulphan versus total body irradiation combined with cyclophosphamide as conditioning for autograft or allograft bone marrow transplantation in patients with acute leukaemia. Acute Leukaemia Working Party of the European Group for B

1 reference

https://pubmed.ncbi.nlm.nih.gov/22856463

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Addition of high-dose Ara-C to the BMT conditioning regimen reduces leukemia relapse without an increase in toxicity

1 reference

https://pubmed.ncbi.nlm.nih.gov/22856463

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/1756-8722-5-46

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Dimensions Publication ID

0 references

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36173285&oldid=2198296738"